Clinical usefulness of alterations in sialic acid, sialyltransferase and sialoproteins in breast cancer

Indian Journal of Clinical Biochemistry

Volumn 19, Issue 2, 2004, Pages 60-71

  Raval, G N ^a   Parekh, L J ^b   Patel, D D ^a   Jha, F P ^a   Sainger, R N ^a   Patel, Prabhudas S ^a  

^a GUJARAT CANCER AND RESEARCH INSTITUTE   (India)

^b M S UNIVERSITY OF BARODA   (India)

Author keywords

Breast Cancer; Glycoproteins; Sialic acid; Sialyltransferase; Tumours

Indexed keywords

GLYCOCONJUGATE; SIALIC ACID; SIALOPROTEIN; SIALYLTRANSFERASE; TUMOR MARKER;

ARTICLE; BLOOD LEVEL; BREAST CANCER; BREAST TUMOR; CANCER STAGING; CLINICAL FEATURE; CONTROLLED STUDY; DIAGNOSTIC VALUE; FEMALE; FOLLOW UP; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; MALIGNANT NEOPLASTIC DISEASE; PROGNOSIS;

EID: 3943099388     PISSN: 09701915     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF02894259     Document Type: Article

References (48)

1. Hakomori, S. (1989) Aberrant glycosylation in tumour and tumour-associated carbohydrate antigens. Adv. Cancer Res. 52, 257-331.
2. Passaniti, A. and Hart, G.W. (1988) Cell surface sialylation and tumour cell metastatic potential of B16 melanoma variants correlates with their relative number of specific penultimate with oligosscharide structure. J. Biol. Chem. 263, 7591-7603.
3. Yogeeswaran, G. (1981) Metastatic potential is positively correlated with cell surface sialylation of cultured murine cell lines. Science 212, 1514-1516.
4. Singhal, A. and Hakomori, S. (1990) Molecular changes in carbohydrate antigens associated with cancer. Bioassays 12, 223-230.
5. Rademacher, T.W., Parekh, R.B., and Dwek, R.A. (1988) Glycobiology. Annu. Rev. Biol. Chem. 57, 785-838.
6. Feijoo, C., Paez-de-la, Cadena, M. and Rodriguezberrocat, F.J. (1997) Sialic acid level in serum and tissue from colorectal cancer patients. Cancer Lett. 112, 155-160.
7. Paszkowaska, A., Berbec, H., Semczuk, A. and Cybulski, M. (1998) Sialic acid concentration in serum and tissue of endometrial cancer patients. Eur. J. Obstet. Gynecol. Reprod. Biol. 76, 211-215.
8. Dall'olio, F. and Trere, D. (1993) Expression of alpha 2,6 sialylated sugar chain in normal and neoplastic colon tissues. Detection by digoxigenin conjugated sambucus nigra aglutinin. Eur. Jr. Histochem. 37, 257-265.
9. Marth, E., Flaschka, G., Stiegler, S. and Mose, J. (1988) Sialic acid as a marker for differentiation between benign and malignant intracranial tumours. Clinica. Chimica. Acta. 176, 251-258.
10. Kelm, S. and Schauer, R. (1997) Sialic acid in molecular and cellular interaction. Int. rev. cytol. 175, 137-240.
11. Gatchev, O., Rastam, L., Lindberg, G., Gullberg, B., Eklund, G.A.and Tornberg, S. (1993) Tumours of the central nervous system and serum sialic acid concentration in men and women. Br. J. cancer 68, 425-427.
12. Schauer, R. and Corfield, A.P. (1982) Occurance of sialic acids - chemistry, metabolism and function. In: Cell biology monographs, Schauer, R. (ed.). Springer Verlag, New York, 10, 5-50.
13. Vierbuchen, M.J., Fruectnicht, W., Brackrock, S., Kranse, K.T. and Zienkiewicz, T.J. (1995) Quantitative lectin histochemical and immunochemical studies on the occurance of alpha 2, 6-linked sialic acid residues in colorectal carcinomas. Relation to clinicopathological features. Cancer 76, 727-735.
14. Holmes, E., Osterander, G. and Hakomori, S. (1986) Biosynthesis of the sialyl -LeX determinant carried out by type-2 chain glycosphingolipids (IV 3 NeuAcIII3 FucnLc4, Vi3NeuAcV3FucnLc6 and Vi3 NeuAcIII3 V3 Fuc2 nLc6) in human lung carcinoma cell lines. J. Biol. Chem. 261, 3737-3743.
15. st edition, 7.
16. Miller, A.B., Hoogstraten, B., Staquet, M. and Winkler, A. (1981) Reporting results of cancer treatment. Cancer 47, 207-214.
17. Skoza, L. and Mohos, S. (1976) Stable thiobarbituric acid chromophore with dimethyl sulfoxide. Application to sialic acid assay in analytical De-O-acetylation. Biochem. J. 159, 457-462.
18. Warren, L., Buck, C.A.and Tuszynski, G.P. (1978) Glycopeptide changes and malignant transformetios: A possible role for carbohydrate in malignant behaviour. Biochim. Biophys. Acta. 516, 97-127.
19. Winzler, R.J. (1955) Determination of serum glycoproteins. In: Methods of biochemical analysis. Vol. 2. New York; Intersciences Publishers, 279-311.
20. Kessel, D. and Allen, J. (1975) Elevated plasma sialyltransferase in the cancer patients. Cancer Res. 35, 670-672.
21. Thompson, S. and Turner, G.A. (1987) Elevated levels of abnormally fucosylated heptoglobins in cancer sera. Br. J. Cancer 56, 605-610.
22. Noursis, M.J. (1996) SPSS for windows. SPSS Advanced stastic release 7.5; SPSS Inc. Chicago.
23. Kaplan, E.L. and Meier, P. (1958) Nonparametric estimation from incomplete observations. J. Am. Stat. Assoc. 53, 457-481.
24. Cox, A.R. (1972) Regression analysis model and life table. J. Stat. Soc. (Br.) 34, 187-198.
25. Patel, P.S., Baxi, B.R., Adhvaryu, S.G. and Balar, D.B. (1990) Evaluation of serum sialic acid, heat stable alkaline phosphatase and fucose as markers of breast carcinoma. Anticancer Res. 10, 1071-1074.
26. Patel, P.S., Raval, G.N., Rawal, R.M., Patel, G.H., Balar, D.B., Shah, P.M.and Patel, D.D. (1995) Comparision between serum levels of carcinoembryonic antigen, sialic acid and phosphohexose isomerase in lung cancer. Neoplasma 42, 53-56.
27. Raval, G.N., Parekh, L.J., Patel, M.M., Patel, P.S., Rawal, R.M., Balar, D.B. and Patel, D.D. (1997) Role of sialic acid and alkaline DNase in breast cancer. The Int. Jr. Biol. Markers 12, 61-67.
28. Kobata, A. and Takasaki, S. (1993) Structural characterization of oligo-saccharides from glycoproteins. In: Glycobiology: A practical approach. Fukuda, M. and Kobata, A. (eds.). Oxford University Press, New York, 165-85.
29. Varki, A. (1993) Biological roles of oligosaccharides: All of the theories are correct. Glycobiology 3, 97-130.
30. Baxi, B.R., Patel, P.S., Adhvaryu, S.G. and Dayal, P.K. (1991) Usefulness of serum glycoconjugates in precancerous and cancerous disease of the oral cavity. Cancer 67, 135-140.
31. Sashikantha, M.C. and Rao, B.B. (1994) Study of serum fucose and serum sialic acid levels in oral squmous cell carcinoma. Ind. J. Dent. Res. 5, 119-124.
32. Gosh, M. and Nayak, B.R. (1991) Serum sialic acid, fucose, sialic acid/fucose ratio as tumour marker in oral cancer. Annals of Densitry 50, 33-35.
33. Ogoshi, K., Miyaji, M., Nakamura, K., Kondoh, Y., Makuuchi, H. and Tajima T. (1997) Immunotherapy and combined assay of serum level of CEA and acute phase reactants. Cancer Immunol. Immunotherapy 46, 14-20.
34. Fernandez-Rodriguez, J., Paez-de-la-cadena, M. and Martinez-zorzano, V.S. (1997) Fucose level in serum and in tumor of colorectal adenocarcinoma patients. Cancer Lett. 121, 147-53.
35. Patel, P.S., Raval, G.N., Patel, M.M., Balar, D.B. and Patel, D.D. (1996) Electrophoretic pattern of serum glycoproteins on polyacrylamide disc gel in patients with breast cancer. Anticancer Res. 16, 2089-2094.
36. Alhadeff, J.A. (1989) Malignant cell glycoproteins and glycolipids. CRC Crit. Rev. in Oncol. Hematol. 9, 37-107.
37. Feizi, T and Childs, R.A. (1987) Carbohydrates as antigenic determinants of glycoproteins. Biochem. J. 245, 1-11.
38. Miles, D.W., Happerfield, L.C., Smith, P., Gillibrand, R., Bobrow, L.G., Gregory, W.M. and Rubens, R.D. (1994) Expression of sialyl Tn predicts the effect of adjuvant chemotherapy in node positive breast cancer. Br. J. Cancer 70, 1272-1275.
39. Muryama, T., Zuber, C., Seelentag, W.K., Li ,W.P., Kemmner, W., Heiz, P.U. and Roth, J.L. (1997) Colon carcinoma glycoprotein carrying alpha 2,6-linked sialic acid reactive with sambucus nigra agglutinin are not constitutively expressed in normal human colon mucosa and are distinct from sialyl Tn antigen. Int. J. Cancer 70, 575-581.
40. Gessner, P., Riedl, S., Quentmaier, A. and Kemmno, W. (1993) Enhanced activity of CMP-NeuAc: Gal beta 1-4GlcNAc:alpha 2-6 Sialyltransferase in metastasizing tumour tissue and serum of tumour patients. Cancer Lett. 75, 143-149.
41. Shimada, I., Shoji, M., Futu-suya, R., Katoh, T., Kominato, Y., Sakamoto, T. and Fujikura, T. (1995) Elevation of ratio of urinary N-acetyl Neuraminlactose to free sialic acids in some advanced cancer patients. J. Gastroentrol. 75, 143-149.
42. Lileng, R., Tved, K., Nesland, J.M., Reed, W., Erikstein, B.K. and Funderud, S. (1993) CDW75 antigen expression in breast cancer. Pathol. Res. Pract. 189, 394-398.
43. Yamamoto, H., Kaneko, Y., Vandermulan, D., Kersey, D., Mkrdichian, E., Leestma, J. and Moskal, J.R. (1995) The expression of CMP-NeUAc: Gal beta 1,4 Glc Nac, alpha 2,6 sialyltransferase (E.C 2.4.99.1) the glycoprotein bearing alpha 2,6-linked sialic acids in human brain tumours. Glycoconjugate J. 12, 848-856.
44. Dao, T.L., Ip, C. and Patel, J. (1980) Serum sialyltransferase and 5′nucleotidase as reliable biomarkers in women with breast cancer. J. Natl. Cancer. Invst. 65, 529-534.
45. Nakata, B., Chung, K.H., Maguruma, K., Yamashita, Y., Inoue, T., Matsuoka, T., Onoda, N., Kato, Y., Sakurai, M. and Sowa, M. (1998) Changes in tumor marker levels as a predictor of chemotherapeutic effect in patients with gastric carcinoma. Cancer 83, 19-24.
46. Suer, S., Sonmez, H., Karaaslan, I., Baloglu, H. and Kokoglu, E. (1996) Tissue sialic acid and fibronectin levels in human prostatic cancer. Cancer Lett. 99, 135-137.
47. Wang, J.W., Ambros, R.A., Weber, P.B. and Rosano, T.G. (1995) Fucosyl transferase and α-L fucosidase and fucose level in normal and malignant endometrial tissue. Cancer Res. 55, 3654-3658.
48. Akamatsu, S., Yazawa, S., Tachikawa, T., Furuta, T., Okaichi, Y., Nakamura, T., Asao, T. and Nagamachi, Y. (1996) Alpha 2-3 sialyltransferase associated with the synthesis of CA19-9 in colorectal tumours. Cancer 77, 1694-1700.